The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Friendly-user score assessing gut dysbiosis and resistance to immune checkpoint inhibitors (ICI).
 
Lisa Derosa
No Relationships to Disclose
 
Carolina Alves Costa Silva
No Relationships to Disclose
 
Valerio Iebba
No Relationships to Disclose
 
Bertrand Routy
No Relationships to Disclose
 
Anna Reni
No Relationships to Disclose
 
Clarisse Audigier-Valette
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Msd (Inst); Novartis (Inst); Pfizer (Inst); Roche; Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Janssen Oncology; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
 
Gerard Zalcman
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Da Volterra; Inventiva Pharma; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Da Volterra (Inst); Inventiva Pharma (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); ROCHE (Inst); ROCHE (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Lilly; Pfizer; Pfizer; Roche
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Sylvie Friard
No Relationships to Disclose
 
François Goldwasser
Consulting or Advisory Role - Baxter; Fresenius Kabi; Nutricia
Research Funding - Baxter
 
Denis Lucien MORO SIBILOT
Consulting or Advisory Role - Bristol-Myers Squibb; Sanofi
Expert Testimony - MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly/ImClone; MSD Oncology; Pfizer; Roche/Genentech
 
Arnaud Scherpereel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Herve Pegliasco
No Relationships to Disclose
 
Stéphanie Martinez
No Relationships to Disclose
 
Bernard Escudier
Honoraria - Ipsen; Oncorena; Pfizer
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Ipsen; Oncorena
Research Funding - Bristol-Myers Squibb (Inst)
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Janssen; MSD; Novartis; Pfizer; Roche; Samsung
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Taiho Pharmaceutical (Inst)
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen; MSD
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Genzyme (Inst); Genzyme (Inst); Hedera Dx (Inst); Inivata (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst); socar (Inst); Taiho Pharmaceutical (Inst); Turning Point Therapeutics (Inst)
 
Fabrice Barlesi
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai Europe (Inst); Lilly (Inst); Merck Serono (Inst); Mirati Therapeutics (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Innate Pharma (Inst); Innate Pharma (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Laurence Zitvogel
Leadership - EverImmune; Hookipa Biotech; Transgene
Stock and Other Ownership Interests - EverImmune
Honoraria - EverImmune; Hookipa Biotech; Transgene
Consulting or Advisory Role - EverImmune; German Cancer Aid; Hookipa Biotech; Pierre Fabre; Transgene
Research Funding - 9 Meters Biopharma; Biomérieux; Daiichi Sankyo; EverImmune; Pileje; Transgene
Patents, Royalties, Other Intellectual Property - EverImmune
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
Other Relationship - Seerave Foundation
(OPTIONAL) Uncompensated Relationships - MaaT Pharma